GDF15 antagonism limits severe heart failure and prevents cardiac cachexia.
Saved in:
| Title: | GDF15 antagonism limits severe heart failure and prevents cardiac cachexia. |
|---|---|
| Authors: | Takaoka M; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Tadross JA; Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science and Medical Research Council, University of Cambridge, Cambridge, UK.; Department of Histopathology, East Midlands & East of England Genomic Laboratory, Cambridge, UK., Al-Hadithi ABAK; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Zhao X; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Villena-Gutiérrez R; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Tromp J; University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.; Saw Swee Hock School of Public Health, National University of Singapore & the National University Health System, Singapore., Absar S; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Au M; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Harrison J; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK., Coll AP; Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science and Medical Research Council, University of Cambridge, Cambridge, UK., Marciniak SJ; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Rimmington D; Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science and Medical Research Council, University of Cambridge, Cambridge, UK., Oliver E; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Centro de Investigaciones Biologicas Margarita Salas (CIB-CSIC), Madrid, Spain., Ibáñez B; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Centro de Investigaciones Biomédicas en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; IIS-Hospital Fundacion Jimenez Diaz, Madrid, Spain., Voors AA; University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., O'Rahilly S; Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science and Medical Research Council, University of Cambridge, Cambridge, UK., Mallat Z; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK.; Paris Cardiovascular Research Center, Université Paris Cité, INSERM UMRS 970, Paris, France., Goodall JC; Department of Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0QQ, UK. |
| Source: | Cardiovascular research [Cardiovasc Res] 2024 Dec 31; Vol. 120 (17), pp. 2249-2260. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1755-3245 |
|---|---|
| DOI: | 10.1093/cvr/cvae214 |
